Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 192

    GSK, Pfizer to Merge Consumer Healthcare units

    GSK, Pfizer to Merge Consumer Healthcare units

    Farhat Nasim20 Dec 2018 9:29 AM IST
    The deal paves the way for British group GSK to have two UK-listed companies, one specialised in the development of drugs and the other in consumer...
    China first to approve AstraZeneca, FibroGen Roxadustat

    China first to approve AstraZeneca, FibroGen Roxadustat

    Medical Dialogues Bureau20 Dec 2018 9:16 AM IST
    Roxadustat is the first of a new kind of oral anaemia treatment called a hypoxia-inducible factor prolyl hydroxylase inhibitor that boosts production...
    Biocon,Mylan get EU approval for biosimilar of cancer drug

    Biocon,Mylan get EU approval for biosimilar of cancer drug

    Medical Dialogues Bureau20 Dec 2018 9:00 AM IST
    "Ogivri, a biosimilar Trastuzumab jointly developed by Biocon and Mylan, has been approved in the EU. The European Commission has granted marketing...
    No online sale of drugs till regulatory rules in place: Delhi High Court

    No online sale of drugs till regulatory rules in place: Delhi High Court

    Farhat Nasim19 Dec 2018 10:33 AM IST
    The observations by the bench were made while hearing the applications moved by some online pharmacies seeking to be impleaded in the matter.New...
    IHH unable to proceed with Fortis open offer after SC status quo on deal

    IHH unable to proceed with Fortis open offer after SC status quo on deal

    Farhat Nasim19 Dec 2018 9:35 AM IST
    The open offer by Fortis for an additional 26 per cent stake was scheduled to commence on December 18 and close on January 1, 2019, entailing a total...
    Glenmark Pharma gets USFDA nod for Fluocinolone Acetonide Oil

    Glenmark Pharma gets USFDA nod for Fluocinolone Acetonide Oil

    Farhat Nasim19 Dec 2018 9:15 AM IST
    Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for...
    Merck strengthens animal health unit with $2.4 billion Antelliq purchase

    Merck strengthens animal health unit with $2.4 billion Antelliq purchase

    Farhat Nasim19 Dec 2018 9:00 AM IST
    The move affirms Merck's commitment to the business, which Wall Street analysts have long seen value in separating just as rival drugmakers Eli Lilly...
    Lupin gets USFDA nod for generic Clobazam Tablets

    Lupin gets USFDA nod for generic Clobazam Tablets

    Farhat Nasim18 Dec 2018 12:29 PM IST
    New Delhi: Pharma major Lupin recently announced that it has received approval for its Clobazam Tablets, 10 mg and 20 mg from the United States Food...
    Glenmark pharma gets ANDA approval for Hydrocortisone Valerate Ointment USP, 0 2 pc

    Glenmark pharma gets ANDA approval for Hydrocortisone Valerate Ointment USP, 0 2 pc

    Medical Dialogues Bureau18 Dec 2018 9:31 AM IST
    Hydrocortisone Valerate Ointment is Glenmark's first granted competitive generic therapy(CGT) product approved by the FDA.Mumbai: Pharma major...
    Junshi Biosciences raises $394 million after pricing IPO at bottom of range

    Junshi Biosciences raises $394 million after pricing IPO at bottom of range

    Farhat Nasim18 Dec 2018 9:00 AM IST
    HONG KONG: Chinese biotech startup Shanghai Junshi Biosciences Co Ltd has raised $394 million after pricing its Hong Kong initial public offering...
    J&J announces $5 billion share repurchase after shares extend losses

    J&J announces $5 billion share repurchase after shares extend losses

    Farhat Nasim18 Dec 2018 8:59 AM IST
    The share repurchase was just the latest effort the healthcare conglomerate has made to boost investor confidence.New Delhi: Johnson & Johnson...
    Madras High Court refuses to set aside stay on online sale of drugs

    Madras High Court refuses to set aside stay on online sale of drugs

    Farhat Nasim17 Dec 2018 9:40 AM IST
    Chennai: The Madras High Court recently refused to set aside the stay order given by it on the issue of the online sale of drugs. It also directed the...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok